The role of overexpressed DYRK1A protein in the early onset of neurofibrillary degeneration in Down syndrome

Clicks: 213
ID: 111732
2008
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Steady

Ranked #126 of 438 articles by views in acta neuropathologica

Most read Least read

Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 438 in total.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
The gene encoding the minibrain kinase/dual-specificity tyrosine phosphorylated and regulated kinase 1A (DYRK1A) is located in the Down syndrome (DS) critical region of chromosome 21. The third copy of DYRK1A is believed to contribute to abnormal brain development in patients with DS. In vitro studies showing that DYRK1A phosphorylates tau protein suggest that this kinase is also involved in tau protein phosphorylation in the human brain and contributes to neurofibrillary degeneration, and that this contribution might be enhanced in patients with DS. To explore this hypothesis, the brain tissue from 57 subjects including 16 control subjects, 21 patients with DS, and 20 patients with sporadic Alzheimer’s disease (AD) was examined with two antibodies to the amino-terminus of DYRK1A (7F3 and G-19), as well as two polyclonal antibodies to its carboxy-terminus (X1079 and 324446). Western blots demonstrated higher levels of full-length DYRK1A in the brains of patients with DS when compared to control brains. Immunocytochemistry revealed that DYRK1A accumulates in neurofibrillary tangles (NFTs) in subjects with sporadic AD and in subjects with DS/AD. Overexpression of DYRK1A in patients with DS was associated with an increase in DYRK1A-positive NFTs in a gene dosage-dependent manner. Results support the hypothesis that overexpressed DYRK1A contributes to neurofibrillary degeneration in DS more significantly than in subjects with two copies of the DYRK1A gene and sporadic AD. Immunoreactivity with antibodies against DYRK1A not only in NFTs but also in granules in granulovacuolar degeneration and in corpora amylacea suggests that DYRK1A is involved in all three forms of degeneration and that overexpression of this kinase may contribute to the early onset of these pathologies in DS.
Reference Key
wegiel2008actathe Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Jerzy Wegiel;Karol Dowjat;Wojciech Kaczmarski;Izabela Kuchna;Krzysztof Nowicki;Janusz Frackowiak;Bozena Mazur Kolecka;Jarek Wegiel;Wayne P. Silverman;Barry Reisberg;Mony deLeon;Thomas Wisniewski;Cheng-Xin Gong;Fei Liu;Tatyana Adayev;Mo-Chou Chen-Hwang;Yu-Wen Hwang;Jerzy Wegiel;Karol Dowjat;Wojciech Kaczmarski;Izabela Kuchna;Krzysztof Nowicki;Janusz Frackowiak;Bozena Mazur Kolecka;Jarek Wegiel;Wayne P. Silverman;Barry Reisberg;Mony deLeon;Thomas Wisniewski;Cheng-Xin Gong;Fei Liu;Tatyana Adayev;Mo-Chou Chen-Hwang;Yu-Wen Hwang;
Journal acta neuropathologica
Year 2008
DOI
doi:10.1007/s00401-008-0419-6
URL
https://link.springer.com/article/10.1007/s00401-008-0419-6
Keywords
pathology neurosciences

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.